Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT.

IF 4.5 2区医学 Q1 HEMATOLOGY

Bone Marrow Transplantation Pub Date : 2024-10-25 DOI:10.1038/s41409-024-02451-8

Piera Angelillo, Ana Alarcon Tomas, Edoardo Campodonico, Urban Novak, Ludovic Gabellier, Igor Wolfgang Blau, Mi Kwon, Ron Ram, Edouard Forcade, Caroline Besley, Vladan Vucinic, Nicolaus Kröger, Lucía López Corral, Jan Vydra, Silvia Ferrari, Bastian von Tresckow, Marie Therese Rubio, Rafael Hernani, Simona Sica, Friedrich Stölzel, Montserrat Rovira, Eva Wagner-Drouet, Jose Antonio Pérez-Simón, Cristina Castilla-Llorente, Andres J M Ferreri, Jorinde D Hoogenboom, Isabel Sanchez Ortega, Florent Malard, Jürgen Kuball, Annalisa Ruggeri

引用次数: 0

查看原文本刊更多论文

欧洲 CAR T 细胞治疗 DLBCL 和 PMBCL 后的严重 ICANS 以及使用左乙拉西坦预防癫痫发作的评估：代表 EBMT 细胞治疗与免疫生物学工作组 (CTIWP) 进行的调查。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bone Marrow Transplantation 医学-免疫学

CiteScore

8.40

自引率

8.30%

发文量

337

审稿时长

6 months

期刊介绍： Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation. The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 24 issues a year.